• Carcinoembryonic Antigen (CEA), Cerebrospinal Fluid
  • Inherited bone marrow failure syndromes (IBMFS) Gene Mutation Panel, NGS
  • Coagulation Factor XI Inhibitor Screen, Plasma
  • TINF2 Gene Mutation Analysis
  • Schistosoma, Antibody, IgG
  • Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • Chromosome Analysis, Hematologic Disorders, Bone Marrow
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Pleural Fluid
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Pleural Fluid
Medical Test

Methodology
Access to Cancer Antigen (CA) 19-9, Pleural Fluid is restricted.